Shan-Fu Wu

Shan-Fu Wu is a highly skilled scientist with extensive experience in molecular assay development for cancer diagnosis and human identification. Currently serving as a Senior Scientist at Guardant Health, Shan-Fu has previously held senior positions at Verogen, DermTech, and Biocept, Inc., where contributions included developing next-generation sequencing (NGS) assays and leading teams in molecular diagnostics. With a solid foundation in oncological sciences and biotechnology, Shan-Fu's academic credentials include a Ph.D. from the University of Utah and a Master's degree from National Taiwan Ocean University, complemented by postdoctoral research at the University of California, San Diego, and the University of Utah. Notable achievements include the successful launch of multiple commercial assays and significant contributions to high-impact publications in developmental biology.